Open Access
Issue
Med Buccale Chir Buccale
Volume 17, Number 3, Août 2011
Page(s) 203 - 209
Section Mises au point / Literature reviews
DOI https://doi.org/10.1051/mbcb/2011115
Published online 22 June 2011
  1. Fleisch H. Bisphosphonates : mechanisms of action. Endocr Rev 1998;19 :80-100. [CrossRef] [PubMed]
  2. Fisher JE, Rodan GA, Reszka AA. In vivo effects of bisphosphonates on the osteoclast mevalonate pathway. Endocrinology 2000;141 :4793-6. [CrossRef] [PubMed]
  3. Wood J, Bonjean K, Ruetz S, Bellahcène A, Devy L, Foidart JM, Castronovo V, Green JR. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002;302 :1055-61. [CrossRef] [PubMed]
  4. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws : a growing epidemic. J Oral Maxillofac Surg 2003;61 :1115-7. [CrossRef] [PubMed]
  5. Mavropoulos A, Rizzoli R, Ammann P. Different responsiveness of alveolar and tibial bone to bone loss stimuli. J Bone Miner Res 2007;22 :403-10. [CrossRef] [PubMed]
  6. Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 2007;41 :318-20. [CrossRef] [PubMed]
  7. Allen MR, Burr DB. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw : so many hypotheses, so few data. J Oral Maxillofac Surg 2009;67(Suppl 5) :61-70. [CrossRef] [PubMed]
  8. O’Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D, Martin D, Liberty D, Lo JC. Intravenous bisphosphonate-related osteonecrosis of the jaw : bone scintigraphy as an early indicator. J Oral Maxillofac Surg 2009;67 :1363-72. [CrossRef] [PubMed]
  9. Lo JC, O’Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez G, Silver P, Chandra M, McCloskey CA, Staffa JA, Willy M, Selby JV, Go AS. Predicting risk of osteonecrosis of the jaw with oral bisphosphonate exposure (PROBE) investigators. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 2010;68 :243-53. [CrossRef] [PubMed]
  10. Dore F, Filippi L. Bone scintigraphy and SPECT/CT in bisphosphonate-induced osteonecrosis of the jaw. J Nucl Med 2009;50 :30-5. [CrossRef] [PubMed]
  11. Abi Najim S. Ostéonécrose des maxillaires et bisphosphonates. Thèse n°664 Médecine dentaire, Genève, 2008.
  12. Bedogni A, Saia G, Ragazzo M, Bettini G, Capelli P, D’Alessandro E, Nocini PF, Lo Russo L, Lo Muzio L, Blandamura S. Bisphosphonate-associated osteonecrosis can hide jaw metastases. Bone 2007;41 :942-5. [CrossRef] [PubMed]
  13. Catalano L, Del Vecchio S, Petruzziello F, Fonti R, Salvatore B, Martorelli C, Califano C, Caparrotti G, Segreto S, Pace L, Rotoli B. Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. Ann Hematol 2007;86 :415-23. [CrossRef] [PubMed]
  14. SPILF III conférence de consensus en thérapeutique anti-infectieuse. In : Médecine et Maladies Infectieuses, Société de Pathologie Infectieuse de Langue Française ed. 1991 :37-44.
  15. Decroisette C. Le traitement des métastases osseuses par les bisphosphonates. Med Nucléaire 2006;30 :164-71.
  16. Murphy KJ, Line BR, Malfetano J. Etidronate therapy decreases the sensitivity of bone scanning with methylene diphosphonate labelled with technetium-99m. Can Assoc Radiol J 1997;48 :199-202. [PubMed]
  17. Tjalma WA, Buytaert PM, Berneman ZN. Reduction of visible bone metastases by clodronate therapy in breast cancer. Eur J Gynaecol Oncol 2001;22 :215-6. [PubMed]
  18. AFSSAPS. Recommandations sur la prise en charge bucco-dentaire des patients traités par bisphosphonates, 2007.
  19. Lee CY, Suzuki JB. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II : a prospective clinical study. Implant Dent 2010;19 :29-38.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.